Re: Where's the added risk? More....SGE1

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Where's the added risk? More....SGE1

in response to

Re: Where's the added risk? More....

SGE1

posted on Feb 20, 2008 01:53AM

In the event that the NDA figures are given, they will only be disclosed to the T3 and subject to a further NDA.

It is also probable that by the time TPL request a change of venue, and a decision is made, the results from the USPTO will be known.

I look forward to the statutory disclosure of the litigation in the next 10Q, as required.